Anti-eNOS antibody [3/eNOS/NOS Type III] - BSA and Azide free
- BOND RX™ Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eNOS antibody [3/eNOS/NOS Type III] - BSA and Azide free (AB282129)
This data was developed using ab282109 the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling eNOS with ab282109 at 1/2000 dilution (0.518 μg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining in endothelial cells of human spleen. The section was incubated with ab282109 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eNOS antibody [3/eNOS/NOS Type III] - BSA and Azide free (AB282129)
This data was developed using ab282109 the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling eNOS with ab282109 at 1/2000 dilution (0.518 μg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining in endothelial cells of mouse spleen. The section was incubated with ab282109 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
- WB
Supplier Data
Western blot - Anti-eNOS antibody [3/eNOS/NOS Type III] - BSA and Azide free (AB282129)
This data was developed using ab282109, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lysates should be made freshly and used in WB immediately to minimize protein degradation.
Negative control : HeLa (PMID : 19559671).
Exposure time : 37 seconds.
All lanes:
Western blot - Anti-eNOS antibody [3/eNOS/NOS Type III] (<a href='/en-us/products/primary-antibodies/enos-antibody-3-enos-nos-type-iii-ab282109'>ab282109</a>) at 1/2000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell), whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
Ea.Hy926 (Human somatic cell hybrid endothelial), whole cell lysate at 20 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
false
- WB
Supplier Data
Western blot - Anti-eNOS antibody [3/eNOS/NOS Type III] - BSA and Azide free (AB282129)
This data was developed using ab282109, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lysates should be made freshly and used in WB immediately to minimize protein degradation.
Exposure time : 3 seconds.
All lanes:
Western blot - Anti-eNOS antibody [3/eNOS/NOS Type III] (<a href='/en-us/products/primary-antibodies/enos-antibody-3-enos-nos-type-iii-ab282109'>ab282109</a>) at 1/5000 dilution
All lanes:
bEnd.3 (mouse brain endothelioma), whole cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
false
Related conjugates and formulations (1)
-
Anti-eNOS antibody [3/eNOS/NOS Type III]
Reactivity data
Product details
ab282129 is the carrier-free version of ab282109.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ENOS contributes significantly to the regulation of vascular tone and blood flow by promoting vasodilation. It does not function alone; instead it forms complexes with other proteins to exert its full effect. eNOS activity influences the process of angiogenesis inflammation modulation and platelet aggregation. Through its ability to produce nitric oxide eNOS acts as a signaling molecule helping maintain vascular homeostasis.
Pathways
ENOS is a critical player in the NO signaling pathway and interacts intricately with the PI3K/Akt pathway. Nitric oxide produced by eNOS has a role in signaling cascades that lead to vascular dilation and reduced blood pressure. The PI3K/Akt pathway regulates eNOS activity via phosphorylation enhancing NO production. Other proteins like caveolin-1 and calmodulin modulate eNOS impacting these pathways' outcomes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com